图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:CELLULAR ONCOLOGY

ISSN:2211-3428
出版频率:Bi-monthly
出版社:SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
  出版社网址:http://www.springer.com/
期刊网址:http://www.springer.com/biomed/cancer/journal/13402
影响因子:6.73
主题范畴:ONCOLOGY;    CELL BIOLOGY;    PATHOLOGY
变更情况:Newly Added by 2012

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Cellular Oncology

Cellular Oncology

The official journal of the International Society for Cellular Oncology

Editor-in-Chief: Prof. A. Geurts van Kessel

ISSN: 2211-3428 (print version)
ISSN: 2211-3436 (electronic version)

Logo ISCO

The Official Journal of the International Society for Cellular Oncology
    • Focuses on translational research
  • Addresses the conversion of cell biology to clinical applications

    Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

    A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the management of cancer patients.

    In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.

    Related subjects » Biomedical Sciences - Cancer Research - Oncology & Hematology - Pathology

    Impact Factor: 2.4 (2012) * 

    Journal Citation Reports®, Thomson Reuters

    Abstracted/Indexed in 

    Science Citation Index, Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, PubMed/Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, CSA, CAB International, Academic Search, Biological Abstracts, BIOSIS, CAB Abstracts, CSA Environmental Sciences, Current Contents/ Life Sciences, Current Contents/Clinical Medicine, Global Health, OCLC, SCImago, Sociedad Iberoamericana de Informacion Cientifica (SIIC) Databases, Summon by Serial Solutions

    Popular Content within this publication 

     

    Ultra-fast processing of gigapixel Tissue MicroArray images using High Performance ComputingWang, Yinhai; McCleary, David; Wang, Ching-Wei Show all authors (7)
    A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cellsWu, Yong; Tang, Min; Wu, Yuan Show all authors (11)

     

     
     

    Aims and scope: Cellular Oncology

    As of 2011, Cellular Oncology will be publishing scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the management of cancer patients. Cellular Oncology publishes original papers, rapid communications, topical reviews, technical notes, special reports and letters.                     

    "In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations."


    Instructions to Authors

    Manuscript submission 

    Manuscript Submission

    Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

    Permissions

    Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

    Online Submission

    Authors should submit their manuscripts online. Electronic submission substantially reduces the editorial processing and reviewing times and shortens overall publication times. Please follow the hyperlink “Submit online” on the right and upload all of your manuscript files following the instructions given on the screen.

    Title page 

    Title Page

    The title page should include:
    • The name(s) of the author(s)
    • A concise and informative title
    • The affiliation(s) and address(es) of the author(s)
    • The e-mail address, telephone and fax numbers of the corresponding author

    Abstract

    Please provide a structured abstract of 150 to 250 words which should be divided into the following sections:
    • Purpose (stating the main purposes and research question)
    • Methods
    • Results
    • Conclusions

    Keywords

    Please provide 4 to 6 keywords which can be used for indexing purposes.

    Text 

    Text Formatting

    Manuscripts should be submitted in Word.
    • Use a normal, plain font (e.g., 10-point Times Roman) for text.
    • Use italics for emphasis.
    • Use the automatic page numbering function to number the pages.
    • Do not use field functions.
    • Use tab stops or other commands for indents, not the space bar.
    • Use the table function, not spreadsheets, to make tables.
    • Use the equation editor or MathType for equations.
    • Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
    Manuscripts with mathematical content can also be submitted in LaTeX.

    Headings

    Please use the decimal system of headings with no more than three levels.

    Abbreviations

    Abbreviations should be defined at first mention and used consistently thereafter.

    Footnotes

    Footnotes can be used to give additional information, which may include the citation of a reference included in the reference list. They should not consist solely of a reference citation, and they should never include the bibliographic details of a reference. They should also not contain any figures or tables.
    Footnotes to the text are numbered consecutively; those to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data). Footnotes to the title or the authors of the article are not given reference symbols.
    Always use footnotes instead of endnotes.

    Acknowledgments

    Acknowledgments of people, grants, funds, etc. should be placed in a separate section before the reference list. The names of funding organizations should be written in full.

    References 

    Citation

    Reference citations in the text should be identified by numbers in square brackets. Some examples:
    • Negotiation research spans many disciplines [3].
    • This result was later contradicted by Becker and Seligman [5].
    • This effect has been widely studied [1-3, 7].

    Reference list

    The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text. Do not use footnotes or endnotes as a substitute for a reference list.
    The entries in the list should be numbered consecutively.
    • Journal article
      S. Preuss, A. Demchuk Jr., M. Stuke, Appl. Phys. A 61, 33 (1995)
    • Article by DOI
      M.K. Slifka, J.L. Whitton, J Mol Med. (2000) doi:10.1007/s001090000086
    • Book
      H. Ibach, H. Lüth, Solid-State Physics, 2nd edn. (Springer, Dordrecht, 1996), pp. 45–56
    • Book chapter
      D.M. Abrams, in Conductive Polymers, ed. By R.S. Seymour, A. Smith (Springer, New York, 1973), p. 307
    • Online document
      J. Cartwright, Big stars have weather too. (IOP Publishing PhysicsWeb, 2007), http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2007
    Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations, see

    Tables 

    • All tables are to be numbered using Arabic numerals.
    • Tables should always be cited in text in consecutive numerical order.
    • For each table, please supply a table caption (title) explaining the components of the table.
    • Identify any previously published material by giving the original source in the form of a reference at the end of the table caption.
    • Footnotes to tables should be indicated by superscript lower-case letters (or asterisks for significance values and other statistical data) and included beneath the table body.

    Artwork and Illustrations Guidelines 

    For the best quality final product, it is highly recommended that you submit all of your artwork – photographs, line drawings, etc. – in an electronic format. Your art will then be produced to the highest standards with the greatest accuracy to detail. The published work will directly reflect the quality of the artwork provided.

    Electronic Figure Submission

    • Supply all figures electronically.
    • Indicate what graphics program was used to create the artwork.
    • For vector graphics, the preferred format is EPS; for halftones, please use TIFF format. MS Office files are also acceptable.
    • Vector graphics containing fonts must have the fonts embedded in the files.
    • Name your figure files with "Fig" and the figure number, e.g., Fig1.eps.

    Line Art

    line-bw
    • Definition: Black and white graphic with no shading.
    • Do not use faint lines and/or lettering and check that all lines and lettering within the figures are legible at final size.
    • All lines should be at least 0.1 mm (0.3 pt) wide.
    • Scanned line drawings and line drawings in bitmap format should have a minimum resolution of 1200 dpi.
    • Vector graphics containing fonts must have the fonts embedded in the files.

    Halftone Art

    halftone-gray-color
    • Definition: Photographs, drawings, or paintings with fine shading, etc.
    • If any magnification is used in the photographs, indicate this by using scale bars within the figures themselves.
    • Halftones should have a minimum resolution of 300 dpi.

    Combination Art

    combined
    • Definition: a combination of halftone and line art, e.g., halftones containing line drawing, extensive lettering, color diagrams, etc.
    • Combination artwork should have a minimum resolution of 600 dpi.

    Color Art

    • Color art is free of charge for online publication.
    • If black and white will be shown in the print version, make sure that the main information will still be visible. Many colors are not distinguishable from one another when converted to black and white. A simple way to check this is to make a xerographic copy to see if the necessary distinctions between the different colors are still apparent.
    • If the figures will be printed in black and white, do not refer to color in the captions.
    • Color illustrations should be submitted as RGB (8 bits per channel).

    Figure Lettering

    • To add lettering, it is best to use Helvetica or Arial (sans serif fonts).
    • Keep lettering consistently sized throughout your final-sized artwork, usually about 2–3 mm (8–12 pt).
    • Variance of type size within an illustration should be minimal, e.g., do not use 8-pt type on an axis and 20-pt type for the axis label.
    • Avoid effects such as shading, outline letters, etc.
    • Do not include titles or captions within your illustrations.

    Figure Numbering

    • All figures are to be numbered using Arabic numerals.
    • Figures should always be cited in text in consecutive numerical order.
    • Figure parts should be denoted by lowercase letters (a, b, c, etc.).
    • If an appendix appears in your article and it contains one or more figures, continue the consecutive numbering of the main text. Do not number the appendix figures, "A1, A2, A3, etc." Figures in online appendices (Electronic Supplementary Material) should, however, be numbered separately.

    Figure Captions

    • Each figure should have a concise caption describing accurately what the figure depicts. Include the captions in the text file of the manuscript, not in the figure file.
    • Figure captions begin with the term Fig. in bold type, followed by the figure number, also in bold type.
    • No punctuation is to be included after the number, nor is any punctuation to be placed at the end of the caption.
    • Identify all elements found in the figure in the figure caption; and use boxes, circles, etc., as coordinate points in graphs.
    • Identify previously published material by giving the original source in the form of a reference citation at the end of the figure caption.

    Figure Placement and Size

    • When preparing your figures, size figures to fit in the column width.
    • For most journals the figures should be 39 mm, 84 mm, 129 mm, or 174 mm wide and not higher than 234 mm.
    • For books and book-sized journals, the figures should be 80 mm or 122 mm wide and not higher than 198 mm.

    Permissions

    If you include figures that have already been published elsewhere, you must obtain permission from the copyright owner(s) for both the print and online format. Please be aware that some publishers do not grant electronic rights for free and that Springer will not be able to refund any costs that may have occurred to receive these permissions. In such cases, material from other sources should be used.

    Accessibility

    In order to give people of all abilities and disabilities access to the content of your figures, please make sure that
    • All figures have descriptive captions (blind users could then use a text-to-speech software or a text-to-Braille hardware)
    • Patterns are used instead of or in addition to colors for conveying information (color-blind users would then be able to distinguish the visual elements)
    • Any figure lettering has a contrast ratio of at least 4.5:1

    Electronic Supplementary Material 

    Springer accepts electronic multimedia files (animations, movies, audio, etc.) and other supplementary files to be published online along with an article or a book chapter. This feature can add dimension to the author's article, as certain information cannot be printed or is more convenient in electronic form.

    Submission

    • Supply all supplementary material in standard file formats.
    • Please include in each file the following information: article title, journal name, author names; affiliation and e-mail address of the corresponding author.
    • To accommodate user downloads, please keep in mind that larger-sized files may require very long download times and that some users may experience other problems during downloading.

    Audio, Video, and Animations

    • Always use MPEG-1 (.mpg) format.

    Text and Presentations

    • Submit your material in PDF format; .doc or .ppt files are not suitable for long-term viability.
    • A collection of figures may also be combined in a PDF file.

    Spreadsheets

    • Spreadsheets should be converted to PDF if no interaction with the data is intended.
    • If the readers should be encouraged to make their own calculations, spreadsheets should be submitted as .xls files (MS Excel).

    Specialized Formats

    • Specialized format such as .pdb (chemical), .wrl (VRML), .nb (Mathematica notebook), and .tex can also be supplied.

    Collecting Multiple Files

    • It is possible to collect multiple files in a .zip or .gz file.

    Numbering

    • If supplying any supplementary material, the text must make specific mention of the material as a citation, similar to that of figures and tables.
    • Refer to the supplementary files as “Online Resource”, e.g., "... as shown in the animation (Online Resource 3)", “... additional data are given in Online Resource 4”.
    • Name the files consecutively, e.g. “ESM_3.mpg”, “ESM_4.pdf”.

    Captions

    • For each supplementary material, please supply a concise caption describing the content of the file.

    Processing of supplementary files

    • Electronic supplementary material will be published as received from the author without any conversion, editing, or reformatting.

    Accessibility

    In order to give people of all abilities and disabilities access to the content of your supplementary files, please make sure that
    • The manuscript contains a descriptive caption for each supplementary material
    • Video files do not contain anything that flashes more than three times per second (so that users prone to seizures caused by such effects are not put at risk)

    Ethical standards 

    Manuscripts submitted for publication must contain a declaration that the experiments comply with the current laws of the country in which they were performed. Please include this note in a separate section before the reference list.

    Conflict of interest 

    All benefits in any form from a commercial party related directly or indirectly to the subject of this manuscript or any of the authors must be acknowledged. For each source of funds, both the research funder and the grant number should be given. This note should be added in a separate section before the reference list.
    If no conflict exists, authors should state: The authors declare that they have no conflict of interest.

    Does Springer provide English language support? 

    Manuscripts that are accepted for publication will be checked by our copyeditors for spelling and formal style. This may not be sufficient if English is not your native language and substantial editing would be required. In that case, you may want to have your manuscript edited by a native speaker prior to submission. A clear and concise language will help editors and reviewers concentrate on the scientific content of your paper and thus smooth the peer review process.
    The following editing service provides language editing for scientific articles in all areas Springer publishes in.
    Use of an editing service is neither a requirement nor a guarantee of acceptance for publication.
    Please contact the editing service directly to make arrangements for editing and payment.

    For Authors from China

    文章在投稿前进行专业的语言润色将对作者的投稿进程有所帮助。作者可自愿选择使用Springer推荐的编辑服务,使用与否并不作为判断文章是否被录用的依据。提高文章的语言质量将有助于审稿人理解文章的内容,通过对学术内容的判断来决定文章的取舍,而不会因为语言问题导致直接退稿。作者需自行联系Springer推荐的编辑服务公司,协商编辑事宜。

    For Authors from Japan

    ジャーナルに論文を投稿する前に、ネイティブ・スピーカーによる英文校閲を希望されている方には、Edanz社をご紹介しています。サービス内容、料金および申込方法など、日本語による詳しい説明はエダンズグループジャパン株式会社の下記サイトをご覧ください。

    For Authors from Korea

    영어 논문 투고에 앞서 원어민에게 영문 교정을 받고자 하시는 분들께 Edanz 회사를 소개해 드립니다. 서비스 내용, 가격 및
    신청 방법 등에 대한 자세한 사항은 저희 Edanz Editing Global 웹사이트를 참조해 주시면 감사하겠습니다.

    After acceptance 

    Upon acceptance of your article you will receive a link to the special Author Query Application at Springer’s web page where you can sign the Copyright Transfer Statement online and indicate whether you wish to order OpenChoice, offprints, or printing of figures in color.
    Once the Author Query Application has been completed, your article will be processed and you will receive the proofs.

    Open Choice

    In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular subscription-based article, but in addition is made available publicly through Springer’s online platform SpringerLink.

    Copyright transfer

    Authors will be asked to transfer copyright of the article to the Publisher (or grant the Publisher exclusive publication and dissemination rights). This will ensure the widest possible protection and dissemination of information under copyright laws.
    Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under the Creative Commons Attribution License.

    Offprints

    Offprints can be ordered by the corresponding author.

    Color illustrations

    Online publication of color illustrations is free of charge. For color in the print version, authors will be expected to make a contribution towards the extra costs.

    Proof reading

    The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
    After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.

    Online First

    The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.

    Editorial Board

    Editor-in-Chief:

    Ad Geurts van Kessel

    Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Geert Grooteplein zuid 10, Nijmegen 6525 GA, Netherlands

    E-mail: cellularoncology@umcn.nl

    Associate Editors:

    Thomas Ried, National Cancer Institute, Bethesda, USA

    Walter Giaretti, National Cancer Institute, Genoa, Italy

    Peter Hamilton, The Queen's University of Belfas, Belfast, UK

    Mario Hermsen, Hospital Universitario Central de Asturias, Oviedo, Spain

    Begoňa Diosdado, VU University Medical Center, Amsterdam, The Netherlands

    Jianping Wang, Sun Yat-sen University, Guangzhou, China

    Editorial Board:

    Donna G. Albertson, San Francisco, USA

    Jan Baak, Stavanger, Norway

    Nick Barker, Singapore, Singapore

    Thomas Cremer, Munich, Germany

    Paul van Diest, Utrecht, The Netherlands

    Manon van Engeland, Maastricht, The Netherlands

    Manel Esteller, Madrid, Spain

    Yuval Garini, Ramat Gan, Israel

    Michael Ghadimi, Göttingen, Germany

    Giuseppe Giaconne, Bethesda, USA

    Françoise Giroud, La Tonce Cedex, France

    Heike Grabsch, Leeds, UK

    Günther Haroske, Dresden, Germany

    Hans Joenje, Amsterdam, The Netherlands

    Olli-Pekka Kallioniemi, Turku, Finland

    Calum MacAulay, Vancouver, Canada

    K. Metze, Campinas, Brazil

    Johan Offerhaus, Utrecht, The Netherlands

    Athanasios Papavassiliou, Athens, Greece

    Iver Petersen, Jena, Germany

    Françoise Praz, Villejuif, France

    Evelin Schröck, Dresden, Germany

    Rosella Silvestrini, Milan, Italy

    Hans Tanke, Leiden, The Netherlands

    Patrick Tan, Singapore, Singapore

    Bauke Ylstra, Amsterdam, The Netherlands



     返回页首 


    邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
    Copyright © 2005-2006 武汉大学图书馆版权所有